Your Article Summary
See Latest ArticlesRecent developments in the classification and assessment of vasculitis
Best Practice & Research: Clinical Rheumatology, 07/01/09
Watts RA et al. - The very complexity of the diseases makes accurate objective assessment critical, especially for the conduct of clinical trials. Several standardized assessment tools for both disease activity and damage have been developed over the past two decades and are now widely used in both clinical trials and routine practice. A second generation of tools is now under development.
Related Articles
European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis
Current Opinion in Rheumatology, 10/16/09
Relevance Score: 92%
Resolution of anti-neutrophil cytoplasmic antibody-associated vasculitis after resection of gastric cancer
Modern Rheumatology, 10/19/09
Relevance Score: 91%
Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9
Journal of Rheumatology, 10/20/09
Relevance Score: 89%
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases
Modern Rheumatology, 10/16/09
Relevance Score: 88%
Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis
Clinical and Experimental Nephrology, 10/09/09
Relevance Score: 88%
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
Is bioptic assurance reasonable in patients with Sjogren’s syndrome
Zeitschrift für Rheumatologie, 12/19/09
HIV-associated Intracranial Aneurysmal Vasculopathy in Adults
Journal of Rheumatology, 12/17/09
Late response to anti-TNF-alpha therapy in refractory mucocutaneous lesions of Behcets disease
Rheumatology International, 12/17/09